A growing body of five-year clinical evidence confirms that short dental implants measuring 5.5 to 6.5 millimetres achieve survival rates between 97% and 100% in the posterior mandible, offering a less invasive and more cost-effective alternative to bone augmentation procedures for patients with limited alveolar ridge height. As of September 2026, multiple peer-reviewed studies now support short implants as a predictable treatment option, reshaping how clinicians approach the resorbed posterior jaw.
For decades, the standard approach to implant placement in the atrophic posterior mandible involved bone grafting or augmentation procedures before placing conventional-length implants. These additional surgeries added cost, healing time, and surgical risk. Now, a convergence of clinical data from studies spanning 2019 through 2026 is challenging that paradigm — and the results are compelling enough to change treatment planning conversations in practices across Canada.
What the Latest Research Shows
As of September 2026, multiple prospective and retrospective studies with five-year follow-up data have evaluated short implants — defined as those measuring 7 millimetres or less in length — in the posterior mandible. The findings are remarkably consistent across research groups and geographies.
A five-year retrospective study published in the Dental Asia September/October 2026 issue reported that 5.5-millimetre and 6.5-millimetre short implants supporting single crowns in the posterior mandible achieved 100% implant and prosthetic survival over the observation period, with minimal marginal bone loss and few manageable complications. The researchers concluded that short implants represent a predictable, less invasive treatment option in selected cases.
This aligns with earlier findings published in peer-reviewed journals. A five-year evaluation of short implants placed in the posterior atrophic mandible reported a cumulative survival rate of 97.8% for implants measuring 5 to 6 millimetres in length, according to data published in PubMed (PMID: 35674172). The study noted favourable outcomes across both survival and prosthetic function metrics.
A separate five-year prospective case series examining 6-millimetre implants supporting single crowns in the resorbed posterior mandible found that these fixtures provide a solid basis for single-tooth restoration, with stable marginal bone levels and high patient satisfaction throughout the follow-up period.
Perhaps most significant for clinical decision-making, a randomised controlled trial comparing 5-millimetre implants against longer implants placed in augmented bone found that short implants achieved similar five-year results — leading the authors to suggest that short implants may be preferable to vertical bone augmentation, particularly in mandibles, because the treatment is faster, less invasive, and more cost-effective.
Why This Matters for Dental Practice in Canada
The clinical significance of these findings extends well beyond the research lab. For Canadian dental practices — particularly those serving aging populations in the Greater Toronto Area and across Ontario — short implants address several practical challenges that clinicians and patients face regularly.
Pro Tip: When presenting short implant options to patients with resorbed ridges, frame the conversation around reduced surgical time (one procedure vs. two), faster return to function (months saved), and lower total treatment cost — these are the factors that drive case acceptance in the posterior mandible.
Reduced surgical complexity. Vertical bone augmentation procedures — including guided bone regeneration, distraction osteogenesis, and onlay grafting — carry inherent risks including donor site morbidity, graft failure, nerve injury, and prolonged treatment timelines. Short implants eliminate or substantially reduce these risks by working within the existing bone volume.
Shorter treatment timelines. A staged approach with bone augmentation typically requires 6 to 12 months of healing before implant placement, followed by another 3 to 6 months of osseointegration. Short implants placed directly into available bone can reduce the total treatment time by 6 to 12 months — a meaningful quality-of-life benefit for patients.
Lower patient costs. Bone grafting materials, membranes, and the additional surgical procedure itself add significant cost to the treatment plan. According to the randomised controlled trial data, the choice of short implants can be preferable specifically because treatment is faster and cheaper than augmentation alternatives.
Expanded treatment access. Medically compromised patients, elderly patients, and those who decline invasive grafting procedures gain access to implant-supported restorations that might otherwise be unavailable to them. In Canada, where an aging population is driving increased demand for implant dentistry, this expanded access has meaningful public health implications.
Clinical Considerations and Patient Selection
The research consistently emphasises that short implant success depends on careful patient selection and meticulous surgical technique. The evidence supports short implants in selected cases — not as a universal replacement for conventional-length implants.
Key factors that influence outcomes with short implants include:
- Bone quality: Dense cortical bone in the posterior mandible provides superior primary stability for short implants compared to the softer bone often found in the maxilla
- Implant diameter: Wider implant platforms compensate for reduced length by increasing the bone-implant contact surface area
- Prosthetic design: Crown-to-implant ratios must be carefully managed to distribute occlusal forces appropriately
- Surface treatment: Modern implant surface modifications (sandblasting, acid-etching, and other roughening techniques) enhance osseointegration even with reduced implant length
- Occlusal loading: Avoiding immediate loading and managing parafunctional habits (bruxism, clenching) is critical for long-term success
Pro Tip: Before selecting a short implant approach, evaluate the patient's occlusal scheme carefully. Patients with heavy bruxism or parafunction may still benefit from augmentation and standard-length implants, where the larger bone-implant interface provides greater resistance to non-axial loading forces.
How Short Implants Fit Into the Broader Implant Market
The global dental implant market surpassed $13 billion USD in 2026, driven by innovation in materials, surface technologies, and digital workflows. Short implants represent a growing segment of this market as manufacturers refine designs specifically optimised for reduced-length applications.
Several major implant manufacturers now offer purpose-designed short implant systems with features including aggressive thread designs for enhanced primary stability, wider platform options to improve the stress distribution profile, and prosthetic connections specifically engineered for higher crown-to-implant ratio scenarios.
Digital workflow integration is further enhancing short implant predictability. Cone-beam computed tomography (CBCT) allows precise measurement of available bone height and proximity to critical structures like the inferior alveolar nerve. Guided surgery protocols enable clinicians to place short implants with sub-millimetre precision, maximising bone-implant contact within the available anatomy.
What Canadian Regulatory Standards Say
In Canada, dental implants are classified as Class III medical devices under Health Canada's Medical Device Regulations. All implant systems used in Canadian practices — including short implant designs — must hold valid Health Canada medical device licences. Clinicians should verify that any short implant system they adopt carries appropriate Health Canada approval and that the manufacturer provides Canadian-specific indications for use documentation.
The Royal College of Dental Surgeons of Ontario (RCDSO) does not prescribe specific implant length requirements, but its Standards of Practice require that treatment planning be evidence-based and that informed consent include a discussion of alternative treatment options. The growing body of five-year evidence for short implants strengthens the clinical rationale for presenting them as a treatment alternative to patients with atrophic ridges.
Looking Ahead: What the Next Decade of Research May Show
While five-year data is clinically significant and sufficient for treatment planning decisions, the implant dentistry community continues to seek longer-term follow-up. Ten-year and fifteen-year prospective studies currently underway will provide additional confidence in the long-term performance of short implants.
Research directions to watch include the combination of short implants with platform-switching concepts (which may further reduce marginal bone loss), the application of new surface nanotechnology to enhance osseointegration in minimal bone volumes, and the use of AI-assisted treatment planning to optimise short implant positioning based on patient-specific anatomical and biomechanical analysis.
For Canadian dental practices, the clinical takeaway from the 2026 evidence is clear: short implants measuring 5.5 to 6.5 millimetres are no longer experimental or marginal. They are a well-supported, predictable treatment option for the right patient — and the evidence base continues to grow.
EBIKO Dental will continue monitoring developments in implant dentistry research as additional long-term data becomes available.
Frequently Asked Questions
Q: Are short dental implants as reliable as standard-length implants?
Five-year clinical data shows short implants (5.5–6.5 mm) achieving survival rates of 97% to 100% in the posterior mandible, comparable to standard-length implants. A randomised controlled trial found similar outcomes between 5-mm implants and longer implants placed in augmented bone, suggesting short implants are a predictable alternative for selected patients.
Q: Who is a good candidate for short dental implants in Canada?
Patients with reduced alveolar ridge height in the posterior mandible who would otherwise require bone augmentation are primary candidates. Good bone quality, adequate implant diameter, and a manageable occlusal scheme are key selection criteria. Patients who are medically compromised, elderly, or who decline invasive grafting procedures may particularly benefit from this less invasive approach.
Q: Do short dental implants cost less than standard implants with bone grafting?
In most cases, yes. Short implants eliminate the need for separate bone augmentation surgery, which involves additional materials (bone graft, membranes), surgical time, and healing periods. The randomised controlled trial evidence specifically notes that short implant treatment is faster and cheaper than the augmentation alternative, making it more accessible for many Canadian patients.